Cefixime
(OKBVVJOGVLARMR-VINNURBNSA-N)
Structure
- SMILES
- Nc1nc(cs1)/C(=N\OCC(=O)O)/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)C=C
- Molecular Formula:
- C16H15N5O7S2
- Molecular Weight:
- 453.450
- Log P:
- 0.3652
- Hydrogen Bond Acceptor:
- 14
- Hydrogen Bond Donor:
- 4
- TPSA:
- 238.05
- CAS Number(s):
- 79350-37-1; 97164-56-2
Synonym(s)
1.
Cefixime
2.
Cefixime Anhydrous
3.
Cefixime Trihydrate
4.
FK 027
5.
FK-027
6.
FR-17027
7.
Suprax
8.
FK027
9.
FR 17027
10.
FR17027
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Pruritus | FAERS: 5 | US FAERS | |
| 2 | Urticaria | FAERS: 4 | US FAERS | |
| 3 | Fatigue | FAERS: 3 | US FAERS | |
| 4 | Abdominal discomfort | FAERS: 2 | US FAERS | |
| 5 | Drug dispensing error | FAERS: 2 | US FAERS | |
| 6 | Drug dose omission | FAERS: 2 | US FAERS | |
| 7 | Drug ineffective | FAERS: 2 | US FAERS | |
| 8 | Hypersensitivity | FAERS: 2 | US FAERS | |
| 9 | Product use issue | FAERS: 2 | US FAERS | |
| 10 | Skin reaction | FAERS: 2 | US FAERS | |
| 11 | Wrong technique in product usage process | FAERS: 2 | US FAERS | |
| 12 | Abdominal Pain | FAERS: 1 | US FAERS | |
| 13 | Angioedema | FAERS: 1 | US FAERS | |
| 14 | Anxiety | FAERS: 1 | US FAERS | |
| 15 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 16 | Burning sensation | FAERS: 1 | US FAERS | |
| 17 | Chest discomfort | FAERS: 1 | US FAERS | |
| 18 | Clostridium difficile infection | FAERS: 1 | US FAERS | |
| 19 | Constipation | FAERS: 1 | US FAERS | |
| 20 | Discomfort | FAERS: 1 | US FAERS | |
| 21 | Disease recurrence | FAERS: 1 | US FAERS | |
| 22 | Dizziness | FAERS: 1 | US FAERS | |
| 23 | Documented hypersensitivity to administered product | FAERS: 1 | US FAERS | |
| 24 | Dyspepsia | FAERS: 1 | US FAERS | |
| 25 | Erythema | FAERS: 1 | US FAERS | |
| 26 | Escherichia infection | FAERS: 1 | US FAERS | |
| 27 | Expired product administered | FAERS: 1 | US FAERS | |
| 28 | Eye irritation | FAERS: 1 | US FAERS | |
| 29 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 30 | Headache | FAERS: 1 | US FAERS | |
| 31 | Impaired work ability | FAERS: 1 | US FAERS | |
| 32 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 33 | Lethargy | FAERS: 1 | US FAERS | |
| 34 | Nocturia | FAERS: 1 | US FAERS | |
| 35 | Pain | FAERS: 1 | US FAERS | |
| 36 | Pancreatitis | FAERS: 1 | US FAERS | |
| 37 | Peripheral swelling | FAERS: 1 | US FAERS | |
| 38 | Therapy change | FAERS: 1 | US FAERS | |
| 39 | Throat irritation | FAERS: 1 | US FAERS | |
| 40 | Vomiting | FAERS: 1 | US FAERS | |
| 41 | Weight decreased | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.